Xact Kapitalforvaltning’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$4.34M Sell
17,910
-77
-0.4% -$20.1K 0.09% 186
2019
Q4
$4.7M Buy
17,987
+646
+4% +$170K 0.08% 227
2019
Q3
$4.72M Buy
17,341
+2,341
+16% +$651K 0.09% 207
2019
Q2
$4.13M Buy
15,000
+112
+0.8% +$27.6K 0.09% 215
2019
Q1
$3.33M Sell
14,888
-587
-4% -$121K 0.08% 241
2018
Q4
$2.88M Buy
15,475
+1,800
+13% +$369K 0.07% 248
2018
Q3
$3.41M Sell
13,675
-768
-5% -$186K 0.07% 260
2018
Q2
$3.15M Hold
14,443
0.07% 290
2018
Q1
$2.76M Buy
14,443
+787
+6% +$145K 0.06% 309
2017
Q4
$2.14M Buy
13,656
+959
+8% +$151K 0.05% 377
2017
Q3
$1.97M Buy
12,697
+662
+6% +$105K 0.06% 369
2017
Q2
$1.94M Sell
12,035
-153
-1% -$24.8K 0.06% 370
2017
Q1
$1.88M Buy
12,188
+1,269
+12% +$175K 0.06% 377
2016
Q4
$1.28M Buy
10,919
+5,145
+89% +$587K 0.04% 440
2016
Q3
$651K Buy
+5,774
New +$609K 0.02% 551

Other funds holding IDXX

Xact Kapitalforvaltning's IDXX Position: Q1 2020 in Review

Xact Kapitalforvaltning reduced its Idexx Laboratories (IDXX) stake by 0.43% in Q1 2020, selling an estimated $20.1K and leaving 17,910 shares worth $4.34M. The position accounts for 0.09% of the portfolio, ranked #186.

Xact Kapitalforvaltning first reported a position in IDXX in Q3 2016 and has held it in 15 quarters since. The position peaked at $4.72M in Q3 2019. 749 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

  • Xact Kapitalforvaltning held 17,910 shares of Idexx Laboratories worth $4.34M as of Q1 2020.
  • Xact Kapitalforvaltning sold 77 Idexx Laboratories shares in Q1 2020, an estimated $20.1K.
  • Idexx Laboratories made up 0.09% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #186 holding.
  • Xact Kapitalforvaltning first reported a position in Idexx Laboratories in Q3 2016 and has held it in 15 quarters since.
  • Xact Kapitalforvaltning's Idexx Laboratories position peaked at $4.72M in Q3 2019.
  • 749 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.